Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;54(2):907-11.
doi: 10.1128/AAC.01080-09. Epub 2009 Dec 7.

Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1

Affiliations

Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1

Thomas A Toni et al. Antimicrob Agents Chemother. 2010 Feb.

Abstract

The selection of drug-resistant variants of human immunodeficiency virus type 1 (HIV-1) is an impediment to the efficiency of antiretroviral (ARV) therapy. We have developed an allele-specific real-time PCR assay to explore the presence of K65R minority species among treated HIV-1 subtype B and C infections. Thirty HIV-1 subtype C- and 26 subtype B-infected patients lacking K65R as determined by conventional sequencing methods were studied, and viral minority species were found in four HIV-1 subtype C samples.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Presence and absence of K65R as a minority species. We tested HIV-1 samples and standards for the presence of the K65R mutation as a minority species by using our novel AS-PCR assay as described in the text. (a) The amplification plots show that K65R was present in subtype C MJ4 K65R plasmid (107 copies/μl). The K65R curve crosses the threshold level earlier than that of the total virus population and of the wild type, indicating the presence of K65R only in the former. Positive results were obtained for each of the four patient samples tested under the same conditions, as shown in panels b, c, d, and e.

References

    1. Brenner, B., D. Turner, M. Oliveira, D. Moisi, M. Detorio, M. Carobene, R. G. Marlink, J. Schapiro, M. Roger, and M. A. Wainberg. 2003. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 17:F1-F5. - PubMed
    1. Coutsinos, D., C. F. Invernizzi, H. Xu, D. Moisi, M. Oliveira, B. G. Brenner, and M. A. Wainberg. 2009. Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1. J. Virol. 83:2029-2033. - PMC - PubMed
    1. Delaunay, C., F. Brun-Vezinet, R. Landman, G. Collin, G. Peytavin, A. Trylesinski, P. Flandre, M. Miller, and D. Descamps. 2005. Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021). J. Virol. 79:9572-9578. - PMC - PubMed
    1. Diallo, K., B. Marchand, X. Wei, L. Cellai, M. Gotte, and M. A. Wainberg. 2003. Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity. J. Virol. 77:8621-8632. - PMC - PubMed
    1. Doualla-Bell, F., A. Avalos, B. Brenner, T. Gaolathe, M. Mine, S. Gaseitsiwe, M. Oliveira, D. Moisi, N. Ndwapi, H. Moffat, M. Essex, and M. A. Wainberg. 2006. High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob. Agents Chemother. 50:4182-4185. - PMC - PubMed

Publication types

MeSH terms